Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-08-13EMA Authorised: Enbrel (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Enbrel (etanercept) for multiple inflammatory diseases including rheumatoid arthritis, ankylosing s…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
This clinical trial update indicates a study evaluating change in psoriasis symptoms in adults with moderate to severe psoriasis treated wit…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Prediction Model for Osteopenia in Patients With Psoriasis
A completed study reports on a prediction model to assess osteopenia risk in patients with psoriasis.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 [Phase 1]
Phase 1 clinical trial update for HS-20118 evaluating safety and PK/PD in psoriasis; study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis
A completed clinical trial evaluating sleep monitoring in adults with moderate-to-severe psoriasis, conducted by the University of Californi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris [Phase 1]
An update on a Phase 1 trial studying immunogenetic profiling of Goeckerman Therapy for psoriasis vulgaris. The study status is terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
This completed study characterized lipoprotein composition and function in pediatric psoriasis patients before and after treatment to explor…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Genetic Variation in TRAF3IP2 (rs13190932) [NA]
A clinical trial is investigating the genetic variation TRAF3IP2 rs13190932 in participants with psoriasis and psoriatic arthritis. The stud…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
A clinical trial update describing a study on disease trajectories and anti-cytokine response signatures in individuals with atopic dermatit…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Molecular Signatures in Inflammatory Skin Disease
A clinical trial listing for a study on molecular signatures in inflammatory skin diseases, recruiting participants for Atopic Dermatitis an…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV) [Phase 4]
Open-label Phase IV study evaluating secukinumab for nail psoriasis and enthesitis in psoriasis patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Rimegepant in Moderate Plaque-type Psoriasis [Phase 2]
Phase 2 study of rimegepant for moderate plaque-type psoriasis has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) [Phase 3]
Arcutis Biotherapeutics completed a Phase 3 trial of ARRECTOR (topical roflumilast) for scalp psoriasis, with results posted in July 2025.
-
EMA approval · 2025-07-17EMA Authorised: Nordimet (methotrexate) — Nordic Group B.V.
EMA authorised Nordimet (methotrexate) by Nordic Group B.V. for use in arthritis-related conditions including rheumatoid arthritis, psoriati…
-
EMA approval · 2025-07-16EMA Authorised: Ilumetri (tildrakizumab) — Almirall, S.A.
The European Medicines Agency has authorised Ilumetri (tildrakizumab) by Almirall for the treatment of psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Clinical Trial of TQH3906 Capsules in Healthy Volunteers [Phase 1]
A Phase 1 study of TQH3906 capsules in healthy volunteers has completed, evaluating safety and pharmacokinetics for potential use in psorias…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement [NA]
A completed clinical trial evaluated the effect of a marula-derived ceramide cream on skin barrier function across several skin conditions, …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis [NA]
A completed clinical trial evaluating whether INulin-type Fructans modulate gut microbiota and the gut-skin axis parameters in psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan
A post-marketing surveillance study evaluating Deucravacitinib for psoriasis in Japan has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis [Phase 1]
This document reports the completion of a Phase 1 study evaluating KX01 Ointment in patients with psoriasis.
-
FDA approval · 2025-07-02FDA Approved: ACITRETIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ACITRETIN from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Assessing Patient Confidence in Biologic Medications [NA]
This is a completed clinical trial assessing patient confidence in biologic medications used for psoriasis. The sponsor is Wake Forest Unive…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
This clinical trial update summarizes the impact of untreated depression and anxiety on patients with skin diseases in Jeddah, Saudi Arabia.…
-
FDA label_change · 2025-06-27FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for Ustekinumab (Stelara) by Janssen Biotech, resulting in updated labeling.